NEWSLETTER – JULY 2023
ALL THE TEAMS AT IDDI WISH YOU A WONDERFUL SUMMER!
Take a break and enjoy some insightful content we are happy to share with you.
NEWS & EVENTS
IDDI ACHIEVES ACCREDITATION IN MEDIDATA RAVE EDC
“Achieving the Medidata Rave EDC accreditation demonstrates IDDI’s dedication to offering our customers an optimal EDC solution. We are confident that in aligning with industry leaders like Medidata, we can deliver the highest level of quality and trusted data for our customers across all trial phases, complexity and therapeutic areas”, says Serge Bodart, CCO IDDI.
eBOOK
eBOOK: THE ULTIMATE GUIDE TO CLINICAL DATA MANAGEMENT
This eBook is a must-read that will enable clinical professionals to better understand the Clinical Data Management (CDM) processes involved in a clinical trial to ensure clinical data is ready for submission.
ON-DEMAND WEBINARS
WHY DO SO MANY PHASE III TRIALS FAIL?
Learn about statistical explanations for a large proportion of Phase III clinical trials failures, and how to address both the overestimation of treatment effects, and the misinterpretation of P-values via Bayesian methods.
THE ADDED VALUE OF BIOSTATISTICS-DRIVEN RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEM
In this joint IDDI/CLARIO case study-focused webinar, the speakers demonstrated how biostatistics is crucial at multiple stages of clinical trials such as study design, randomization implementation, rerandomization needs, randomization and drug supply checks, unblinding and final analysis.
GPC – A NOVEL STATISTICAL METHOD FOR OUTCOME ANALYSIS AND REPORTING OF PRIORITIZED COMPOSITE ENDPOINTS
Learn how the Generalized Pairwise Comparisons – GPC method can be used to design clinical trials with multiple endpoints. You will also understand the differences between the GPC treatment effect measures: the net treatment benefit, success odds and win ratio.
ALL THE RECORDINGS AND PRESENTATIONS OF OUR WEBINARS ARE AVAILABLE ON OUR IDDI WEBINAR WEBPAGE.
PODCAST
GPC – A NOVEL STATISTICAL METHOD FOR OUTCOME ANALYSIS AND REPORTING OF PRIORITIZED COMPOSITE ENDPOINTS
Learn how the Generalized Pairwise Comparisons – GPC method can be used to design clinical trials with multiple endpoints. You will also understand the differences between the GPC treatment effect measures: the net treatment benefit, success odds and win ratio.
OPTIMIZING YOUR CLINICAL DEVELOPMENT STRATEGY
- Aiming at optimizing your clinical development strategy, IDDI consultants provide expert advice in clinical trial, regulatory statistics and innovative approaches to design optimal development programs with the greatest potential for commercial success and improved patient outcomes.
- Our Consultant Team provides support at the Regulatory Authorities (FDA/EMA): statistical input is often critical for regulatory interactions, either to discuss specific statistical analyses or to assess statistical implications of clinical trial designs or clinical development programs.
SPOTLIGHT ON THE STATISTICAL CONSULTING AND RESEARCH TEAM
WELCOME TO VINCENT STAGGS, PhD
We are happy to welcome Vince in the Statistical Consulting & Research team as Senior Scientist and excited to see the team grow and expand to the US.
Vince has a M.S. in Mathematics from Missouri State University and a PhD in Quantitative Psychology from the University of Kansas. He previously served as the Director of the Biostatistics & Epidemiology Core at Children’s Mercy Research Institute and as a faculty member of the School of Medicine at the University of Missouri-Kansas City. Some areas of his expertise include Bayesian hierarchical modeling, clinical trial design, and psychometrics.
CONFERENCES & MEETINGS
We look forward to meeting you at conferences to discuss your needs for your upcoming trials. We combine advanced biostatistics, regulatory and medical expertise, and innovative integrated eClinical solutions to increase efficiency and mitigate risks throughout the drug development process.
- 11- 12 JULY ARENA: Clinical Operations in Oncology Trials East Coast – Boston Booth # 15
Meet Shruti Jituri and Kalyn Dozier - 3-7 SEPT: CEN (Central Europan Network Conference) – Basel, Switzerland |
Meet Erik Falvey - 26-27 SEPT: ARENA: Outsourcing in Clinical Trials Southern California, La Jolla
Meet Shruti Jituri - 26 SEPT: Bioforward – Oxford, UK | Meet Erik Falvey
HR NEWS
WE KEEP ON GROWING – WE KEEP ON HIRING!
We are looking for talents to join our growing team in Belgium and the USA! Are you ready for new challenges in helping biotech and pharma companies develop new drugs and treatments? Apply today!
JOIN OUR INNOVATIVE AND GROWING TEAM – WE ARE HIRING!
Well-Being & Fun at IDDI
“Well-being is the experience of health, happiness, and prosperity. It includes having good mental health, high life satisfaction, a sense of meaning or purpose, and the ability to manage stress. More generally, well-being is just feeling well”. Definition from Berkeley Well-being Institute.
IDDI strives to promote a healthy work-life balance and encourages self-care, self-compassion and self-advocacy.
ABOUT IDDI : BIOSTATISTICS & CLINICAL DATA SCIENCE EXPERTS
Founded in 1991, IDDI is an expert clinical data services and high-level strategic consulting contract research organization offering Trial Design – Randomization – Data Management and Biostatistics services for Pharmaceutical, Biotech & medical device/diagnostic companies.
ANY UPCOMING RFP/RFI?